EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) 21. September 2017, section EUDA news
13. February 2026 Action on drug precursors: first EU-level precursor assessment reports published Illicit drug production poses a growing threat to public health and security in Europe. Monitoring drug precursor markets...
